Fiducial Markers Market To Reach USD 127.3 Million By 2027 | Top Key Players Boston Scientific Corporation, Naslund Medical AB, Carbon Medical Technologies

Rising occurrence of cancer is one of the significant factors influencing the market growth.

The global fiducial markers market is expected to reach USD 127.3 Million by 2027, according to a new report by Reports and Data. Fiducial markers find usage in image-guided radiotherapy procedures, where the placement of the markers is by modalities such as computed tomography (CT) or ultrasound, among others, and may encompass the application of an endoscope. Fiducial markers assist in precisely locating a tumor, thereby allowing the radiologist or a team of radiologists to provide the maximum radiation dosage to the tumor while mitigating the dose radiation imparted to healthy tissue in the vicinity.

The growing prevalence of cancer is a significant factor in driving the fiducial markers market growth. Cancer has a significant impact on global society, including the US. Detection of the disease at an early stage significantly increases the chances of survival. Creating awareness to encourage early diagnosis and screening are the crucial steps responsible for early detection of the disease. Identifying likely warning symptoms of the disease and taking rapid measures is necessary for early diagnosis. Greater awareness of probable symptoms of cancer amongst physicians, nurses, and other healthcare providers, in addition to the general public, would positively impact the survival rate and hence would be instrumental in increasing the market demand. The American Cancer Society proposes that in 2020, over 1.8 million individuals are likely to be diagnosed with cancer, of which various patients would require a blood transfusion, occasionally on a daily basis.

Additionally, a growing inclination towards fiducial markers in stereotactic radiosurgery is of significant importance in propelling the market growth. Stereotactic surgery is a form of minimally invasive surgical technique used to treat functional defects and small tumors of the brain. This minimally invasive surgery is meant especially for those patients having tumors and abnormalities that are hard to reach, subject to movement within the body, or located close to vital organs and anatomic regions.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3471

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Fiducial Markers market in these key regions.

Further key findings from the report suggest

• By type, metal-based markers contributed to the largest fiducial markers market size in 2019. Metal-based markers such as gold fiducial markers find widespread application owing to the offering of benefits like a high contrast level and better visualization.

• By modalities, ultrasound is likely to grow at a rate of 4.7% in the forecast period for the fiducial markers market, attributed to a lower level of toxicity associated with ionizing radiation, as well as cost-effectiveness as compared to other forms of modalities.

• By cancer type, lung cancer is likely to witness a growth rate of 4.8% in the forecast period for the fiducial markers market. It may occur due to various reasons, including smoking, genetic, and exposure to toxic gases. The American Cancer Society projects over 228,000 lung cancer cases, with the occurrence of the disease being higher in men than women. It is a significant cause of death in both US men and women dying due to cancer.

• The fiducial markers market in the Asia Pacific region is expected to grow at the fastest rate of 5.5% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities the diagnostic procedures, among others.

• Key participants include Boston Scientific Corporation, Naslund Medical AB, Carbon Medical Technologies, Stellar Medical, CIVCO Radiotherapy, Medtronic, Innovative Oncology Solutions, IZI Medical Products, Nanovi A/S, and Eckert & Ziegler, among others.

• In December 2019, IZI Medical Products, LLC, a leading fiducial markers market player, made an announcement about the acquisition of RadioMed, the producer of VISICOIL™, an implantable fiducial marker.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3471

For the purpose of this report, Reports and Data have segmented the global fiducial markers market on the basis of type, modalities, application, end-user, and region:

Type Outlook (Revenue, USD Million; 2017-2027)

• Metal-Based Markers
• Polymer-Based Markers
• Others

Modalities Outlook (Revenue, USD Million; 2017-2027)

• Computed Tomography/Computer-Based Computed Tomography
• Magnetic Resonance Imaging
• Ultrasound
• Radiotherapy

Application Outlook (Revenue, USD Million; 2017-2027)

• Prostate cancer
• Lung Cancer
• Breast Cancer
• Gastric Cancer
• Others

End-User Outlook (Revenue, USD Million; 2017-2027)

• Hospitals
• Radiotherapy Centers
• Academic & Research Centers

Regional Outlook (Revenue, USD Million; 2017-2027)

• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Benelux
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Rest of Latin America
• MEA
o Saudi Arabia
o UAE
o Rest of the Middle East and Africa

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3471

Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.

Read More Reports:-

Crizotinib Market @ https://www.google.com.my/url?q=https://www.reportsanddata.com/report-detail/crizotinib-market

Biocompatible 3D Printing Materials Market @ https://www.google.co.ve/url?q=https://www.reportsanddata.com/report-detail/biocompatible-3d-printing-materials-market

Automated Dispensing Machine Market @ https://www.google.com.sv/url?q=https://www.reportsanddata.com/report-detail/automated-dispensing-machine-market

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.